Based on what is known about its drug class and the enrollment criteria of clinical trials, retatrutide should be avoided in the following cases: The side effects most commonly linked to retatrutide in clinical trials involved the gastrointestinal tract
[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Aroda V.R., Edelstein S.L., Goldberg R.B., Knowler W.C., Marcovina S.M., Orchard T.J., Bray G.A., Schade D.S., Temprosa M.G., White N.H., et al
The exact dosing and administration instructions will be provided by your healthcare provider or as indicated in the product's prescribing information
Totowa, NJ 500 Union Blvd, Totowa, NJ 07512 Conveniently located near the intersection of Route 46, 23 and 80
Note that this threshold is a general principle extrapolated from criteria used for licensed anti-obesity medicines (such as those in NICE TA875 for semaglutide and the 2024 NICE technology appraisal for tirzepatide)